Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Mersana Therapeutics Inc - SIC # 8731 - COMMERCIAL PHY_SICAL AND BIOLOGICAL RESEARCH
Ticker
Exchange
SIC #
Website
Latest Ticker
MRSN
Nasdaq
8731
https://www.mersana.com/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Mersana Therapeutics Inc
Strength Seen in Curis (CRIS): Can Its 19.5% Jump Turn into More Strength?
- Apr 5th, 2024 12:43 pm
Mersana Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- Apr 4th, 2024 8:30 pm
Mersana Therapeutics, Inc. (NASDAQ:MRSN) Q4 2023 Earnings Call Transcript
- Feb 29th, 2024 1:41 pm
An Intrinsic Calculation For Mersana Therapeutics, Inc. (NASDAQ:MRSN) Suggests It's 26% Undervalued
- Feb 29th, 2024 11:34 am
Mersana Therapeutics Full Year 2023 Earnings: Revenues Disappoint
- Feb 29th, 2024 11:19 am
Q4 2023 Mersana Therapeutics Inc Earnings Call
- Feb 29th, 2024 2:49 am
Mersana Therapeutics, Inc. (MRSN) Reports Q4 Loss, Lags Revenue Estimates
- Feb 28th, 2024 1:10 pm
Mersana Therapeutics Inc (MRSN) Reports Fourth Quarter and Full Year 2023 Financial Results
- Feb 28th, 2024 12:35 pm
Mersana Therapeutics Provides Business Update and Announces Fourth Quarter and Full Year 2023 Financial Results
- Feb 28th, 2024 12:00 pm
Mersana Therapeutics to Present at Upcoming Investor Conferences
- Feb 27th, 2024 1:01 pm
Stoke Therapeutics, Inc. (STOK) Expected to Beat Earnings Estimates: Should You Buy?
- Feb 26th, 2024 3:00 pm
Mersana Therapeutics to Host Fourth Quarter and Year End 2023 Conference Call on February 28, 2024
- Feb 21st, 2024 1:00 pm
Mersana Therapeutics, Inc. (MRSN) May Report Negative Earnings: Know the Trend Ahead of Q4 Release
- Feb 20th, 2024 3:00 pm
Mersana Therapeutics to Participate in Guggenheim’s 6th Annual Biotechnology Conference
- Feb 1st, 2024 1:00 pm
Mersana Therapeutics Announces Business Updates, Expected 2024 Milestones and Upcoming Presentation at the 42nd Annual J.P. Morgan Healthcare Conference
- Jan 5th, 2024 1:01 pm
The past three years for Mersana Therapeutics (NASDAQ:MRSN) investors has not been profitable
- Jan 2nd, 2024 11:17 am
Mersana Therapeutics, Inc. (NASDAQ:MRSN) Q3 2023 Earnings Call Transcript
- Nov 8th, 2023 7:42 pm
Q3 2023 Mersana Therapeutics Inc Earnings Call
- Nov 8th, 2023 5:13 am
Mersana Therapeutics Inc (MRSN) Reports Q3 2023 Financial Results
- Nov 7th, 2023 1:10 pm
Mersana Therapeutics Provides Business Update and Announces Third Quarter 2023 Financial Results
- Nov 7th, 2023 12:00 pm
Scroll